Full 4th Circ. Urged To Rethink Drug Price-Fixing Class Action
By Hayley Fowler · March 13, 2025, 4:56 PM EDT
The Fourth Circuit's dismissal of a proposed class action accusing drug companies of conspiring to inflate the price of a drug for Huntington's disease has deepened a circuit split on proving...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login